Search This Blog

Monday, August 3, 2020

Neurocrine Biosciences EPS beats by $0.40, beats on revenue

Neurocrine Biosciences (NASDAQ:NBIX): Q2 Non-GAAP EPS of $1.42 beats by $0.40; GAAP EPS of $0.81 beats by $0.15.
Revenue of $302.4M (+64.7% Y/Y) beats by $40.74M.
Press Release

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)